-
1
-
2
Comorbidity in in patients with relapsing-remitting multiple sclerosis
Published 2024-10-01Subjects: Get full text
Article -
3
Improvements in quality of life of patients with multiple sclerosis receiving alemtuzumab in clinical practice: the LEMVIDA study
Published 2024-12-01Subjects: Get full text
Article -
4
-
5
Safety and persistence of dimethyl fumarate as a treatment for relapsing-remitting multiple-sclerosis
Published 2021-03-01Subjects: Get full text
Article -
6
Prognostic Value of CXCL13, CCL11, and CCL20 Chemokines in Multiple Sclerosis
Published 2024-12-01Subjects: “…relapsing–remitting multiple sclerosis…”
Get full text
Article -
7
Profile of Ofatumumab in the Treatment of Multiple Sclerosis: Design, Development and Place in Therapy
Published 2024-12-01Subjects: Get full text
Article -
8
Flow cytometry identifies changes in peripheral and intrathecal lymphocyte patterns in CNS autoimmune disorders and primary CNS malignancies
Published 2024-11-01Subjects: Get full text
Article